Bluebird bio Inc (NASDAQ:BLUE) has a beta value of 0.81 and has seen 2.15 million shares traded in the recent trading session. The company, currently valued at $177.42M, closed the recent trade at $0.92 per share which meant it lost -$0.01 on the day or -1.31% during that session. The BLUE stock price is -501.09% off its 52-week high price of $5.53 and 7.61% above the 52-week low of $0.85. The 3-month trading volume is 6.55 million shares.
Bluebird bio Inc (NASDAQ:BLUE) trade information
Sporting -1.31% in the red today, the stock has traded in the red over the last five days, when the BLUE stock price touched $0.92 or saw a rise of 6.83%. Year-to-date, Bluebird bio Inc shares have moved -33.30%, while the 5-day performance has seen it change -4.96%. Over the past 30 days, the shares of Bluebird bio Inc (NASDAQ:BLUE) have changed -13.16%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Bluebird bio Inc (BLUE) estimates and forecasts
The company’s shares have lost -67.81% over the past 6 months, compared to 15.40% for the industry. Revenue growth from the last financial year stood is estimated to be 881.40%.
10 analysts offering their estimates for the company have set an average revenue estimate of 10.37M for the current quarter. 8 have an estimated revenue figure of 18.38M for the next ending quarter. Year-ago sales stood 62k and 2.38M respectively for this quarter and the next, and analysts expect sales will grow by 16,625.80% for the current quarter and 881.40% for the next.
Earnings growth for 2024 is a modest 9.45% while over the next 5 years, the company’s earnings are expected to increase by 45.80%.
BLUE Dividends
Bluebird bio Inc is expected to release its next earnings report in July this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
